JB Chemicals Reports Strong Q3 2025 Growth: Net Sales Up 10.51%, Profit Jumps 21.79%

• JB Chemicals and Pharmaceuticals announced consolidated net sales of Rs 1,064.72 crore in December 2025, marking a 10.51% year-over-year increase.
• The company's quarterly net profit rose significantly by 21.79% to Rs 197.89 crore in December 2025, compared to Rs 162.49 crore in December 2024.
• EBITDA for December 2025 stood at Rs 314.10 crore, showing a robust growth of 19.65% from the previous year.
• Earnings Per Share (EPS) for JB Chemicals increased to Rs 12.63 in December 2025 from Rs 10.46 in December 2024.
• JB Chemicals shares closed at Rs 1,926.70 on January 16, 2026, delivering 14.36% returns over 6 months and 6.89% over 12 months.

Why It Matters: JB Chemicals demonstrated strong financial performance in Q3 2025 with double-digit growth in sales and profit.